K

Korean Drug Co Ltd
KOSDAQ:014570

Watchlist Manager
Korean Drug Co Ltd
KOSDAQ:014570
Watchlist
Price: 4 290 KRW 0.12% Market Closed
Market Cap: 47.2B KRW

Operating Margin
Korean Drug Co Ltd

5.6%
Current
18%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
5.6%
=
Operating Profit
3.5B
/
Revenue
62.7B

Operating Margin Across Competitors

No Stocks Found

Korean Drug Co Ltd
Glance View

Market Cap
46.4B KRW
Industry
Pharmaceuticals

KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Icheon, Gyeonggi-Do and currently employs 256 full-time employees. The company went IPO on 2000-12-07. The Company’s products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.

Intrinsic Value
4 301.19 KRW
Fairly Valued
Intrinsic Value
Price
K
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
5.6%
=
Operating Profit
3.5B
/
Revenue
62.7B
What is the Operating Margin of Korean Drug Co Ltd?

Based on Korean Drug Co Ltd's most recent financial statements, the company has Operating Margin of 5.6%.

Back to Top